Varadhan M, Passi I, Chinnathangavel T, Rajendiran V
IUCrdata. 2025; 10(Pt 1):x241240.
PMID: 39927307
PMC: 11799777.
DOI: 10.1107/S2414314624012409.
Kasalovic M, Jelaca S, Dimic D, Maksimovic-Ivanic D, Jevtic V, Mijatovic S
Pharmaceutics. 2025; 16(12.
PMID: 39771508
PMC: 11679857.
DOI: 10.3390/pharmaceutics16121529.
Lee L, Lo K
Small Methods. 2024; 8(11):e2400563.
PMID: 39319499
PMC: 11579581.
DOI: 10.1002/smtd.202400563.
Zhang C, Yuan H, Shen H, Ye J, Wang C
Heliyon. 2024; 10(16):e35479.
PMID: 39229538
PMC: 11369472.
DOI: 10.1016/j.heliyon.2024.e35479.
Elias M, Aputen A, Fatima S, Mann T, Karan S, Mikhael M
Int J Mol Sci. 2024; 25(15).
PMID: 39125821
PMC: 11312340.
DOI: 10.3390/ijms25158252.
Anticancer Effect of PtPHEN, Pt5ME, Pt56ME and Their Platinum(IV)-Dihydroxy Derivatives against Triple-Negative Breast Cancer and Cisplatin-Resistant Colorectal Cancer.
Elias M, Fatima S, Mann T, Karan S, Mikhael M, de Souza P
Cancers (Basel). 2024; 16(14).
PMID: 39061185
PMC: 11274883.
DOI: 10.3390/cancers16142544.
Shining New Light on Biological Systems: Luminescent Transition Metal Complexes for Bioimaging and Biosensing Applications.
Lee L, Lo K
Chem Rev. 2024; 124(15):8825-9014.
PMID: 39052606
PMC: 11328004.
DOI: 10.1021/acs.chemrev.3c00629.
Minimal Functionalization of Ruthenium Compounds with Enhanced Photoreactivity against Hard-to-Treat Cancer Cells and Resistant Bacteria.
Oliveira G, Gouveia Jr F, Andrade A, Vasconcelos M, Teixeira E, Palmeira-Mello M
Inorg Chem. 2024; 63(31):14673-14690.
PMID: 39042379
PMC: 11304396.
DOI: 10.1021/acs.inorgchem.4c02235.
Tetranuclear Polypyridylruthenium(II) Complexes as Selective Nucleic Acid Stains for Flow Cytometric Analysis of Monocytic and Epithelial Lung Carcinoma Large Extracellular Vesicles.
Wardhani K, Levina A, Sun B, Zou H, Grau G, Keene F
Biomolecules. 2024; 14(6).
PMID: 38927067
PMC: 11202172.
DOI: 10.3390/biom14060664.
Cell viability imaging in tumor spheroids DNA binding of a ruthenium(II) light-switch complex.
Ramu V, Wijaya L, Beztsinna N, Van de Griend C, van de Water B, Bonnet S
Chem Commun (Camb). 2024; 60(49):6308-6311.
PMID: 38818705
PMC: 11181008.
DOI: 10.1039/d4cc01425a.
Necroptosis induced by ruthenium (II) complexes as mitochondrial disruptors.
Goncalves J, Amaral J, Capela R, Perry M, Braga C, Gaspar M
Cell Death Discov. 2024; 10(1):261.
PMID: 38806468
PMC: 11133381.
DOI: 10.1038/s41420-024-02033-z.
Phenazine Cations as Anticancer Theranostics.
Noakes F, Smitten K, Maple L, Bernardino de la Serna J, Robertson C, Pritchard D
J Am Chem Soc. 2024; 146(18):12836-12849.
PMID: 38683943
PMC: 11082890.
DOI: 10.1021/jacs.4c03491.
Trimethyltin(IV) Bearing 3-(4-Methyl-2-oxoquinolin-1(2H)-yl)propanoate Causes Lipid Peroxidation-Mediated Autophagic Cell Death in Human Melanoma A375 Cells.
Kasalovic M, Dimic D, Jelaca S, Maksimovic-Ivanic D, Mijatovic S, Zmejkovski B
Pharmaceuticals (Basel). 2024; 17(3).
PMID: 38543158
PMC: 10975498.
DOI: 10.3390/ph17030372.
Lysosome-targeted ruthenium(II) complex encapsulated with pluronic F-127 induces oncosis in A549 cells.
Pan N, Zhang Y, Huang M, Liang Z, Gong Y, Chen X
J Biol Inorg Chem. 2024; 29(2):265-278.
PMID: 38189962
DOI: 10.1007/s00775-023-02039-5.
Unprecedented enantio-selective live-cell mitochondrial DNA super-resolution imaging and photo-sensitizing by the chiral ruthenium polypyridyl DNA "light-switch".
Huang R, Huang C, Chen J, Yan Z, Tang M, Shao J
Nucleic Acids Res. 2023; 51(22):11981-11998.
PMID: 37933856
PMC: 10711558.
DOI: 10.1093/nar/gkad799.
Ru(ii)/Os(ii)-based carbonic anhydrase inhibitors as photodynamic therapy photosensitizers for the treatment of hypoxic tumours.
Wang Y, Mesdom P, Purkait K, Saubamea B, Burckel P, Arnoux P
Chem Sci. 2023; 14(42):11749-11760.
PMID: 37920359
PMC: 10619633.
DOI: 10.1039/d3sc03932c.
Triarylphosphine-Coordinated Bipyridyl Ru(II) Complexes Induce Mitochondrial Dysfunction.
Mitchell R, Gowda A, Olivelli A, Huckaba A, Parkin S, Unrine J
Inorg Chem. 2023; 62(28):10940-10954.
PMID: 37405779
PMC: 11886966.
DOI: 10.1021/acs.inorgchem.3c00736.
An Overview of the Potential Medicinal and Pharmaceutical Properties of Ru(II)/(III) Complexes.
Skoczynska A, Lewinski A, Pokora M, Paneth P, Budzisz E
Int J Mol Sci. 2023; 24(11).
PMID: 37298471
PMC: 10253973.
DOI: 10.3390/ijms24119512.
Synthesis and Antiproliferative Insights of Lipophilic Ru(II)-Hydroxy Stearic Acid Hybrid Species.
Drius G, Bordoni S, Boga C, Monari M, Fiori J, Esposito E
Molecules. 2023; 28(10).
PMID: 37241793
PMC: 10222286.
DOI: 10.3390/molecules28104051.
From Chemotherapy to Phototherapy - Changing the Therapeutic Action of a Metallo-Intercalating Ru -Re Luminescent System by Switching its Sub-Cellular Location.
Saeed H, Jarman P, Sreedharan S, Mowll R, Auty A, Chauvet A
Chemistry. 2023; 29(34):e202300617.
PMID: 37013945
PMC: 10946911.
DOI: 10.1002/chem.202300617.
